Eyepoint Pharmaceuticals Inc share price logo

Eyepoint Pharmaceuticals Inc Share Price

NASDAQ: EYPT

Small Cap

$13.29

+0.06

(+0.45%)

Live

as on

Eyepoint Pharmaceuticals Inc Stock Performance

as on March 24, 2026 at 2:07 am IST

  • Day's Low

    Day's High

    $13.04
    $13.55
    downward going graph

    1.88%

    Downside

    1.96%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.91
    $19.11
    downward going graph

    70.58%

    Downside

    43.79%

    Upside

    downward going graph

Eyepoint Pharmaceuticals Inc share price movements today

Previous Close
$13.23
Open
$13.36
Volume
235.3K
Day's Low - High
$13.04 - $13.55
52 Week Low - High
$3.91 - $19.11

Eyepoint Pharmaceuticals Inc Historical Returns

1 Month Return
-22.5 %
3 Month Return
-28.02 %
1 Year Return
+ 111.68 %
3 Year Return
+ 467.81 %
5 Year Return
+ 24.69 %

Eyepoint Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Eyepoint Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.1B

EPS (TTM)

-3.242

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-241.1M

Revenue (TTM)

31.4M

Profit Margin

0.00%

Return On Equity TTM

-72.19%

Eyepoint Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Eyepoint Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Eyepoint Pharmaceuticals Inc image
Eyepoint Pharmaceuticals Inc
BUY$1.1B24.69%NA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.4B125.13%133.418.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.3B112.56%29.6732.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA1115.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.5B56.01%17.6731.41%

Stock Returns calculator for Eyepoint Pharmaceuticals Inc Stock including INR - Dollar returns

The Eyepoint Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Eyepoint Pharmaceuticals Inc investment value today

Current value as on today

₹2,22,559

Returns

₹1,22,559

(+122.56%)

Returns from Eyepoint Pharmaceuticals Inc Stock

₹1,12,640 (+112.64%)

Dollar Returns*

₹9,919 (+9.92%)

Analyst Recommendation on Eyepoint Pharmaceuticals Inc Stock

Based on 16 analysts

BUY

93.75%

Buy

6.25%

Hold

0.00%

Sell

Based on 16 analysts, 93.75% of analysts recommend a 'BUY' rating for Eyepoint Pharmaceuticals Inc. Average target price of $37.42

Eyepoint Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Eyepoint Pharmaceuticals Inc.

What analysts predicted

64.48%UPSIDE

Target Price

$37.42

Current Price

$13.29

Analyzed by

16 Analysts

Target

$37.42

Eyepoint Pharmaceuticals Inc target price $37.42, a slight upside of 64.48% compared to current price of $13.29. According to 16 analysts rating.

Eyepoint Pharmaceuticals Inc Stock’s Investor Sentiment and Interest

Search interest for Eyepoint Pharmaceuticals Inc Stock has increased by 9% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:9% versus previous 30 day period

Eyepoint Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
15
14
11
9
10
11
24
5
0
0
Gross Profit
14
13
10
8
9
10
23
5
0
0
Operating Income
-14
-16
-33
-34
-32
-45
-48
-62
-62
-70
EBITDA
-12
-13
-28
-30
-28
-40
-48
-61
-59
-70
Interest Expense
-
-
-
-
-
0
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-12
-14
-29
-30
-29
-41
-45
-59
-59
-67
Income Tax Expense
1
0
0
-
-
0
-
0
-
0
Net Income
-12
-14
-29
-30
-29
-41
-45
-59
-59
-67
Net Profit Margin
-82.96%
-100.51%
-250.63%
-325.27%
-278.99%
-357.26%
-184.82%
-1114.31%
-6183.44%
-10904.68%

Eyepoint Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
7
2
20
34
36
41
46
43
31
Gross Profit
1
7
-15
17
28
28
33
41
39
29
Operating Income
-21
-18
-26
-47
-37
-55
-99
-75
-145
-243
EBITDA
-20
-17
-36
-48
-35
-50
-96
-69
-129
-243
Interest Expense
-
0
0
6
7
5
3
1
0
0
Depreciation
0
1
-
2
2
2
2
0
1
2
Income Before Tax
-21
-18
-53
-56
-45
-58
-102
-70
-130
-231
Income Tax Expense
0
0
-25
6
7
5
22
0
0
0
Net Income
-21
-18
-53
-56
-45
-58
-102
-70
-130
-231
Net Profit Margin
-1330.06%
-245.19%
-1795.71%
-278.88%
-131.82%
-158.14%
-246.97%
-153.84%
-302.43%
-739.42%

Eyepoint Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-14
-29
-30
-29
-41
-45
-59
-59
-67
Operating Cash Flow
-23
-31
-20
-39
-35
-53
-62
-59
-65
Investing Cash Flow
-47
20
-160
16
-95
39
48
55
-74
Financing Cash Flow
218
0
0
11
151
0
0
7
166
Change in Cash
148
-10
-180
-10
19
-14
-14
3
27

Eyepoint Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-18
-53
-56
-45
-58
-102
-70
-130
-231
Operating Cash Flow
-20
-21
-56
-14
-50
-65
1
-126
-240
Investing Cash Flow
13
-16
0
0
-33
-17
-3
-219
68
Financing Cash Flow
8
60
33
37
216
0
187
164
173
Change in Cash
1
21
-23
22
133
-82
185
-181
2

Global Institutional Holdings in Eyepoint Pharmaceuticals Inc

Funds
Holdings
Suvretta Capital Management, LLC
9.38%
Morgan Stanley - Brokerage Accounts
1.17%
Patient Square Capital
1.96%
5AM Venture Management, LLC
1.26%
Bank of America Corp
1.21%
See all

Insights on Eyepoint Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, EYPT has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, EYPT has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, EYPT stock has moved up by 111.7%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 4 quarters, 24.45M → 620.0K (in $), with an average decrease of 65.3% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 6 quarters, -29.36M → -67.60M (in $), with an average decrease of 19.1% per quarter

About Eyepoint Pharmaceuticals Inc

psivida corp., (nasdaq: psdv) (asx: pva) headquartered in watertown, ma, develops tiny, sustained release, drug delivery products designed to deliver drugs at a controlled and steady rate for months or years. psivida is currently focused on treatment of chronic diseases of the back of the eye utilizing its core technology systems, durasert™ and biosilicon™. the injectable, sustained release micro-insert iluvien® for the treatment of chronic diabetic macula edema (dme), licensed to alimera sciences, inc., has received marketing authorization in austria, france, germany, portugal, the u.k. spain, and italy. iluvien for dme has recently been approved in the us. psivida plans to institute pivotal phase iii clinical trials for the treatment of posterior uveitis with the same micro-insert as iluvien for dme. an investigator-sponsored clinical trial is ongoing for an injectable, bioerodible micro-insert to treat glaucoma and ocular hypertension. psivida's two fda-approved products, retisert®
OrganisationEyepoint Pharmaceuticals Inc
Headquarters480 Pleasant Street, Watertown, MA, United States, 02472
IndustryHealth Technology
CEODr. Jay S. Duker M.D.
E-voting on sharesClick here to vote

Key Management of Eyepoint Pharmaceuticals Inc

Name

Title

Ms. Jennifer Leonard

Chief People Officer & Senior VP of IT

Mr. David Scott Jones M.A.

Senior Vice President

Mr. Michael J. Maciocio

Chief Manufacturing Officer

Mr. Michael Campbell

Chief Commercial Officer

Dr. Ramiro Ribeiro M.D., Ph.D.

Chief Medical Officer

Dr. Marcia Sellos-Moura Ph.D.

Chief Scientific Officer

Mr. Ron I. Honig Esq.

Chief Legal Officer & Company Secretary

Dr. Jay S. Duker M.D.

President, CEO & Director

Mr. George O. Elston CPA

Executive VP & CFO

Ms. Isabelle Lefebvre

Chief Regulatory Officer

FAQs

What is Eyepoint Pharmaceuticals Inc share price today?

Eyepoint Pharmaceuticals Inc share price today is $13.29 as on . Eyepoint Pharmaceuticals Inc share today touched a day high of $13.55 and a low of $13.04.

What is the 52 week high and 52 week low for Eyepoint Pharmaceuticals Inc share?

Eyepoint Pharmaceuticals Inc share touched a 52 week high of $19.11 on and a 52 week low of $3.91 on . Eyepoint Pharmaceuticals Inc stock price today i.e. is trending at $13.29,which is 30.46% down from its 52 week high and 239.90% up from its 52 week low.

What is Eyepoint Pharmaceuticals Inc's market capitalisation today?

Eyepoint Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Eyepoint Pharmaceuticals Inc Stock (EYPT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Eyepoint Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Eyepoint Pharmaceuticals Inc Shares that will get you 0.1129 shares as per Eyepoint Pharmaceuticals Inc share price of $13.29 per share as on March 23, 2026 at 8:37 pm IST.

What is the minimum amount required to buy Eyepoint Pharmaceuticals Inc Stock (EYPT) from India?

Indian investors can start investing in Eyepoint Pharmaceuticals Inc (EYPT) shares with as little as ₹94.058 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹940.58 in Eyepoint Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Eyepoint Pharmaceuticals Inc share’s latest price of $13.29 as on March 23, 2026 at 8:37 pm IST, you will get 0.7524 shares of Eyepoint Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Eyepoint Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Eyepoint Pharmaceuticals Inc stock has given 24.69% share price returns and 29.13% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?